BriaCell Therapeutics Corp. (BCT.TO)
BriaCell Therapeutics Corp.
Bellevue Centre
Suite 300 235 -15th Street
West Vancouver, BC V7T 2X1
Canada
604-921-1810
https://briacell.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 16
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. William V. Williams M.D. | CEO, President & Director | 1.06M | N/A | 1955 |
| Mr. Gadi Levin B.Com., C.A., CPA, M.B.A. | CFO & Corporate Secretary | 409.48k | N/A | 1973 |
| Dr. Miguel A. Lopez-Lago Ph.D. | Chief Scientific Officer | 401.99k | N/A | 1969 |
| Dr. Giuseppe Del Priore M.D., M.P.H., MPH | Chief Medical Officer | 662.37k | N/A | 1962 |
| Dr. Charles Louis Wiseman FACP, M.D. | Founder, Principal Research Advisor & Member of Scientific Advisory Board | 324.31k | N/A | 1946 |
Description
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Corporate Governance
BriaCell Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
